Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Bismuth Subnitrate
Zoetis UK Limited
QG52X
Bismuth Subnitrate
Intramammary suspension
POM-V - Prescription Only Medicine – Veterinarian
Cattle
Miscellaneous Mechanical Teat Seal
Authorized
2002-06-25
Revised: September 2023 AN: 01843/2022 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Orbeseal Dry Cow 2.6 g intramammary suspension for cattle 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 4 g intramammary syringe contains: ACTIVE SUBSTANCE: Bismuth subnitrate, heavy 2.6 g (equivalent to Bismuth, heavy 1.858 g) EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS Liquid paraffin Aluminium Di Tri Stearate Silica, Colloidal Anhydrous Greyish white, smooth, unctuous intramammary suspension. 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Cattle (dairy cow at drying-off). 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES Prevention of new intramammary infections throughout the dry period. In cows considered likely to be free of sub-clinical mastitis, the veterinary medicinal product can be used on its own in dry cow management and mastitis control. 3.3 CONTRAINDICATIONS See section 3.7 “Use during pregnancy, lactation or lay”. Do not use the veterinary medicinal product alone in cows with sub-clinical mastitis at drying off. Do not use in cows with clinical mastitis at drying off. Revised: September 2023 AN: 01843/2022 Page 2 of 6 Do not use in cases of hypersensitivity to the active substance or to any of the excipients. 3.4 SPECIAL WARNINGS Selection of cows for treatment with the veterinary medicinal product should be based on veterinary clinical judgement. Selection criteria may be based on the mastitis and cell count history of individual cows or recognised tests for the detection of subclinical mastitis or bacteriology sampling. 3.5 SPECIAL PRECAUTIONS FOR USE Special precautions for safe use in the target species: It is good practice to observe dry cows regularly for signs of clinical mastitis. If a sealed quarter develops clinical mastitis, the affected quarter should be stripped out manually before appropriate therapy is instituted. To reduce the risk of contamination, do not immerse the syringe in water. Use the syringe only once. Since the ve Read the complete document